- Report
- September 2025
- 100 Pages
Global
From €4323EUR$4,900USD£3,785GBP
- Report
- November 2025
- 183 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- December 2025
- 275 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- December 2025
- 283 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 194 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 179 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 194 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- December 2025
- 270 Pages
Global
From €5161EUR$5,850USD£4,519GBP
- Report
- May 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- January 2025
- 250 Pages
Global
From €4410EUR$4,999USD£3,862GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,594GBP
€3485EUR$3,950USD£3,052GBP
- Book
- April 2023
North America

Cirrhosis is a condition in which the liver becomes scarred and unable to function properly. It is a common complication of chronic liver diseases such as hepatitis, alcohol abuse, and fatty liver disease. Symptoms of cirrhosis include jaundice, fatigue, abdominal pain, and fluid buildup in the abdomen. Treatment for cirrhosis includes lifestyle changes, medications, and in some cases, liver transplantation.
The cirrhosis market is a subset of the hepatology market, which focuses on the diagnosis and treatment of liver diseases. The cirrhosis market is composed of pharmaceuticals, biologics, and medical devices used to treat cirrhosis. These products are used to reduce symptoms, slow the progression of the disease, and improve quality of life.
Companies in the cirrhosis market include AbbVie, Gilead Sciences, Merck, Novartis, and Pfizer. Show Less Read more